Advancing Novel CAR Therapies Through a Comprehensive Discovery Engine

2:15 pm - Tuesday 9th February 2027

  • Identifying novel solid tumour targets through bioinformaticsdriven discovery to establish a strong foundation for CAR development
  • Screening receptors and performing functional assays with patient-derived samples and in vitro models to select the optimal candidate for in vivo evaluation
  • Evaluating data to select a candidate for preclinical development

Speakers:

Co-Founder & Chief Scientific Officer
Immunokey